Related Experiment Videos
HLA markers for susceptibility and expression in scleroderma.
Dafna D Gladman1, Tabitha N Kung, Fotios Siannis
1Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital, Ontario, Canada. dafna.gladman@utoronto.ca
The Journal of Rheumatology
|August 4, 2005
Summary
Specific human leukocyte antigen (HLA) alleles influence scleroderma susceptibility and disease features. This study clarifies the complex role of HLA types in scleroderma development and expression.
Area of Science:
- Immunogenetics
- Rheumatology
- Dermatology
Background:
- Conflicting associations between human leukocyte antigen (HLA) alleles and scleroderma susceptibility and features exist.
- Understanding the genetic basis of scleroderma is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate the role of HLA alleles in scleroderma susceptibility.
- To determine the association of HLA alleles with various aspects of scleroderma disease expression.
Main Methods:
- Prospective cohort study of 95 Caucasian scleroderma patients and 416 controls.
- Clinical data collected via chart review; molecular HLA typing performed using polymerase chain reaction/sequence-specific oligonucleotides.
- Statistical analyses included Fisher's exact test and logistic/linear regression models.
Main Results:
- HLA-DRB1*01 and HLA-DRB1*11 were associated with susceptibility; HLA-DRB1*07 was protective.
- Specific HLA alleles correlated with diffuse skin involvement, high skin scores, and pulmonary complications (fibrosis, hypertension).
- Absence of anticentromere antibodies linked to high skin scores.
Conclusions:
- HLA alleles significantly influence both susceptibility to scleroderma and its clinical manifestations.
- Specific HLA types are associated with disease severity and organ involvement.
- Further research into HLA's role can refine scleroderma understanding and management.